SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG
0
Add to list
GB COVID-19 Ag POCT
Cat. No. 4ECO101E
More details>
(3 items)
SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG About GBC Our Brands R&D Media Join us Contact us
English 繁體中文
In Vitro Diagnostics (IVD)
Menu
GB CL CEA Product
Carcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion. After birth, CEA synthesis is suppressed, resulting in extremely low levels in the blood of healthy adults. However, CEA is abundantly produced in human colon adenocarcinoma and has been clinically correlated with other cancers.
USEFUL RESOURCES
Add to List
>  PRODUCT DESCRIPTION>  PERFORMANCE>  SPECIFICATION>  ORDERING INFORMATION
PRODUCT DESCRIPTION
GB CL CEA Product is intended for in vitro diagnostic (IVD) use. It utilizes the principle of chemiluminescent microparticle immunoassay (CMIA) and a quantitative sandwich assay to measure the concentration of carcinoembryonic antigen (CEA) in human serum and plasma.The assay is performed using the "GBC Chemiluminescence Analyzer (Non-Sterile)."
PERFORMANCE
Limit of Quantitation (LoQ): 0.32 ng/mL
PrecisionVariabilityCoefficient of variation, CV (%)
Repeatabilitywithin run<10%
Reproducibilitybetween-run/between-day<10%
between-sites/between-operators<10%
between-lots<10%
SPECIFICATION
PrincipleSandwich-type chemiluminescent immunoassay 
Assay formatQuantification
Rreaction time10 minutes
Sample typeSerum/Plasma
Sample volume30 μL 
Detection unitRelative light unit (RLU)
Storage2-8°C. Avoid exposure to direct sunlight. Do not freeze.
CertificationRUO
ORDERING INFORMATION
Catalogue No.Product
4ACEA02GB CL CEA
4ACEA1BGB CL CEA-Control
4ACEA2BGB CL CEA-Calibrator